Literature DB >> 3298046

Obesity-induced hypertension in the dog.

A P Rocchini, C Moorehead, E Wentz, S Deremer.   

Abstract

To study the relationship between body weight and blood pressure, we have developed an animal model of obesity-induced hypertension. Nine adult mongrel dogs were chronically instrumented with aortic and vena caval catheters. After a 2-week control period, all dogs were made to gain weight by adding 2 lb/day of beef fat to their diet for 5 weeks. Blood pressure, heart rate, and body weight were measured daily before the addition of dietary fat, during the 5 weeks of the high fat diet, and for 6 weeks after the fat supplement was stopped. Plasma volume and cardiac output were measured prior to and after 5 weeks of the fat diet. During the 5-week high fat diet, the dogs' body weight increased from 22.2 +/- 2.1 to 27.4 +/- 3 kg (p less than 0.001); mean blood pressure increased from 90 +/- 5 to 112 +/- 6 mm Hg (p less than 0.01); and heart rate increased from 70 +/- 7 to 85 +/- 5 beats/min (p less than 0.05). Blood pressure, heart rate, and body weight returned to near control values after the fat diet was stopped. Over the 5-week fat diet, the dogs' plasma volume increased from 920 +/- 130 to 1059 +/- 195 ml (p less than 0.05); cardiac output increased from 2.5 +/- 0.4 to 3.1 +/- 0.3 L/min (p less than 0.05); and systemic vascular resistance increased from 35.3 +/- 8 to 38.9 +/- 9 mm Hg/L/min (p less than 0.1). Weight gain in the dogs was also associated with hyperinsulinemia and insulin resistance.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3298046     DOI: 10.1161/01.hyp.9.6_pt_2.iii64

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

1.  Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study.

Authors:  Meredith C Foster; Shih-Jen Hwang; Stacy A Porter; Joseph M Massaro; Udo Hoffmann; Caroline S Fox
Journal:  Hypertension       Date:  2011-09-19       Impact factor: 10.190

2.  Differences in blood volume components between hyporesponders and responders to erythropoietin alfa: the heart failure with preserved ejection fraction (HFPEF) anemia trial.

Authors:  Margarita Borovka; Sergio Teruya; Julissa Alvarez; Stephen Helmke; Mathew S Maurer
Journal:  J Card Fail       Date:  2013-10       Impact factor: 5.712

Review 3.  Animal Models of Hypertension: A Scientific Statement From the American Heart Association.

Authors:  Lilach O Lerman; Theodore W Kurtz; Rhian M Touyz; David H Ellison; Alejandro R Chade; Steven D Crowley; David L Mattson; John J Mullins; Jeffrey Osborn; Alfonso Eirin; Jane F Reckelhoff; Costantino Iadecola; Thomas M Coffman
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

4.  Serial changes in norepinephrine kinetics associated with feeding dogs a high-fat diet.

Authors:  Albert P Rocchini; John Q Yang; Marla J Smith; Mark A Supiano
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-02-01       Impact factor: 3.738

5.  Effects of low-fat high-fibre diet and mitratapide on body weight reduction, blood pressure and metabolic parameters in obese dogs.

Authors:  Cristina Peña; Lourdes Suarez; Inmaculada Bautista-Castaño; M Candelaria Juste; Elena Carretón; José Alberto Montoya-Alonso
Journal:  J Vet Med Sci       Date:  2014-06-11       Impact factor: 1.267

6.  Weight-gain induced changes in renal perfusion assessed by contrast-enhanced ultrasound precede increases in urinary protein excretion suggestive of glomerular and tubular injury and normalize after weight-loss in dogs.

Authors:  Daisy J X Liu; Emmelie Stock; Bart J G Broeckx; Sylvie Daminet; Evelyne Meyer; Joris R Delanghe; Siska Croubels; Mathias Devreese; Patrick Nguyen; Evelien Bogaerts; Myriam Hesta; Katrien Vanderperren
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

7.  A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients.

Authors:  Alain Bousquet-Mélou; Anne Lespine; Jean-François Sutra; Isabelle Bargues; Pierre-Louis Toutain
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.